The ASAP Guide to Biopharmaceutical Partnering

This supplement to the ASAP Handbook of Alliance Management was created to give alliance professionals in biopharma the specialized frameworks and insights they need to partner successfully in this industry. 

Biopharma partnerships are high stakes, unusually long term, and often have patient lives on the line. A single alliance can span years of discovery, development, regulatory review, commercialization, and change — all hinging on the successful collaboration between organizations with different science, priorities, processes, and cultures. 

The ASAP Guide to Biopharmaceutical Partnering applies the principles of alliance management to this complex environment. Developed with experienced biopharma alliance professionals, it explores how to manage partnerships across the asset life cycle, from the deal through execution, evolution, and eventual wind-down. 

What you'll explore

  • Biopharma alliances and the Alliance Life Cycle

  • Managing the transition from deal-making to execution 

  • Governance, alignment, and “influencing without authority”
  • Alliance wind-down, termination, and divestiture
  • Integration of alliances acquired via M&A activity
  • Alliances involving academia, pharma, biotech, digital health, and more
  • Discovery, development, and commercialization alliances

The guide also includes frameworks, checklists, key questions, examples, worksheets, and additional resources designed specifically for biopharma partnership work. 

Three types of risk

The end goal of development alliances in biopharma is to register a drug with regulatory bodies around the world, including the FDA (US), EMA (EU), and NICE (UK). This means these alliances must contend with a unique combination of business, human, and legal risks.  

In this environment, anything that hinders or delays achieving the goal of drug registration becomes a risk, costing time, money, and potentially human lives.

Alliance management in biopharma is about minimizing these risks through partner alignment, regulatory compliance, and maintaining focus on the shared goal of moving a drug successfully through development and, ultimately, to patients. 

Click here to see an overview of the supplement.

 

Who is it for? 

Whether you’re moving into biopharma alliance management for the first time or managing an established portfolio of partnerships, the ASAP Guide to Biopharmaceutical Partnering provides industry-specific context to complement the principles and frameworks in the ASAP Handbook of Alliance Management. 

ASAP members save 20% on publications.